MicroRNA ‐192‐5p inhibits migration of triple negative breast cancer cells and directly regulates Rho GTPase activating protein 19

Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma

(2019) Nicole Huge et al.   Hepatology International

Identification of dysregulated miRNAs in triple negative breast cancer: A meta-analysis approach

(2018) Leimarembi Devi Naorem et al.   JOURNAL OF CELLULAR PHYSIOLOGY

An HNF4α–microRNA-194/192 signaling axis maintains hepatic cell function

(2017) Aoi Morimoto et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The microRNA-449 family inhibits TGF-β-mediated liver cancer cell migration by targeting SOX4

(2017) Maria Sandbothe et al.   JOURNAL OF HEPATOLOGY

Ensembl 2018

(2017) Daniel R Zerbino et al.   NUCLEIC ACIDS RESEARCH

SMG-1 inhibition by miR-192/-215 causes epithelial-mesenchymal transition in gastric carcinogenesis via activation of Wnt signaling

(2017) Xiaojing Zhang et al.   Cancer Medicine

MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2

(2016) Rajdeep Das et al.   CANCER RESEARCH

A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer

(2016) Sherry Y. Wu et al.   Nature Communications

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer

(2016) Jingdan Qiu et al.   Journal of Cancer

Pattern of metastasis and outcome in patients with breast cancer

(2015) L. Gerratana et al.   CLINICAL & EXPERIMENTAL METASTASIS

Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review

(2015) Saira R. Ali et al.   DRUG DEVELOPMENT RESEARCH

miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma

(2015) Junwei Lian et al.   Oncotarget

The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine

(2015) Lao H Saal et al.   Genome Medicine

Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab

(2014) L. Castagnoli et al.   CANCER RESEARCH

Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma

(2014) JING ZHANG et al.   ONCOLOGY REPORTS

BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer

(2013) Fen Hu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Genetic Susceptibility to Triple-Negative Breast Cancer

(2013) K. N. Stevens et al.   CANCER RESEARCH

miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma

(2013) H.W.Z. Khella et al.   CARCINOGENESIS

MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis

(2013) Atsushi Terunuma et al.   JOURNAL OF CLINICAL INVESTIGATION

miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms

(2012) U. Senanayake et al.   CARCINOGENESIS

Histone Deacetylases Activate Hepatocyte Growth Factor Signaling by Repressing MicroRNA-449 in Hepatocellular Carcinoma Cells

(2012) Reena Buurman et al.   GASTROENTEROLOGY

Modulation of MicroRNA-194 and Cell Migration by HER2-Targeting Trastuzumab in Breast Cancer

(2012) Xiao-Feng Le et al.   PLoS One

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

(2012) Ethan Cerami et al.   Cancer Discovery

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

(2011) Brian D. Lehmann et al.   JOURNAL OF CLINICAL INVESTIGATION

microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer

(2011) YEUNPO CHIANG et al.   Experimental and Therapeutic Medicine

Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development

(2010) Flavia Pichiorri et al.   CANCER CELL

Cytotoxicity Mediated by Histone Deacetylase Inhibitors in Cancer Cells: Mechanisms and Potential Clinical Implications

(2009) D. S. Schrump   CLINICAL CANCER RESEARCH

p53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle Arrest

(2008) C. J. Braun et al.   CANCER RESEARCH

Dual mechanism of δEF1 expression regulated by bone morphogenetic protein-6 in breast cancer

(2008) Shuang Yang et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

(2008) Cornelia Liedtke et al.   JOURNAL OF CLINICAL ONCOLOGY

Inducible expression of microRNA-194 is regulated by HNF-1  during intestinal epithelial cell differentiation

(2008) K. Hino et al.   RNA